Authors: Antman, K Lagakos, S Drazen, J

Citation: K. Antman et al., Designing and funding clinical trials of novel therapies., N ENG J MED, 344(10), 2001, pp. 762-763

Authors: Harel, Z Lilly, C Riggs, S Vaz, R Drazen, J

Citation: Z. Harel et al., Urinary leukotriene (LT) E-4 in adolescents with dysmenorrhea: A pilot study, J ADOLES H, 27(3), 2000, pp. 151-154

Authors: Dellaripa, PF Wechsler, ME Roth, ME Drazen, J

Citation: Pf. Dellaripa et al., Recurrent panniculitis in a man with asthma receiving treatment with leukotriene-modifying agents, MAYO CLIN P, 75(6), 2000, pp. 643-645

Authors: Drazen, J Meyers, DA Thompson, P Dahlen, SE Prescott, S Hall, IP Fabbri, L Holgate, S Le Gros, S Bleecker, G Picado, C Busse, W Martinez, F Warner, J

Citation: J. Drazen et al., Discussion session A: The early life origins of asthma, CLIN EXP AL, 28, 1998, pp. 26-28

Authors: Boner, A Weiss, S Magnussen, H Warner, J Fabbri, L Naspitz, C Drazen, J Prescott, S Sears, M von Mutius, E Bonini, S

Citation: A. Boner et al., Discussion Session B: Early life environmental factors in asthma, CLIN EXP AL, 28, 1998, pp. 50-51

Authors: Bleecker, E Dahlen, SE Warner, J Chung, F Leff, J Haahtela, T Holgate, ST Smith, L Drazen, J Bousquet, J Wenzel, S Johnston, S Naspitz, C

Citation: E. Bleecker et al., Discussion Session E: Determinants in asthma morbidity, CLIN EXP AL, 28, 1998, pp. 171-173